MDLZ Mondelez International, Inc.
Food and Kindred Products · Nasdaq · SEC CIK 1103982 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.0%
TTM net income YoY15.5%
TTM EPS YoY19.1%
Revenue 3-yr CAGR4.1%
Net income 3-yr CAGR-3.9%
Margins
Gross margin34.3%
Operating margin13.7%
Net margin10.2%
FCF margin9.2%
EBITDA margin16.6%
Returns
ROE15.5%
ROA5.7%
ROIC (approx.)9.3%
Asset turnover0.56x
Leverage & solvency
Liabilities / assets62.9%
Debt / equity0.75x
Current ratio0.62x
Interest coverage9.21x
Cash quality & payout
Operating cash flow / net income1.23x
Accruals ratio-1.3%
Payout ratio63.1%
Capex / revenue3.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $38.54B | $36.44B | $36.02B | $31.50B | $28.72B |
| Cost of revenue | $27.60B | $22.18B | $22.25B | $20.18B | $17.47B |
| Gross profit | $10.94B | $14.26B | $13.76B | $11.31B | $11.25B |
| R&D expense | $400.00M | $400.00M | $380.00M | $346.00M | $347.00M |
| SG&A expense | $7.17B | $7.44B | $8.00B | $7.38B | $6.26B |
| Operating income | $3.55B | $6.34B | $5.50B | $3.53B | $4.65B |
| Interest expense | $599.00M | $508.00M | $550.00M | $428.00M | $365.00M |
| Pretax income | $3.01B | $6.26B | $5.88B | $3.23B | $4.37B |
| Income tax | $782.00M | $1.47B | $1.54B | $865.00M | $1.19B |
| Net income | $2.45B | $4.61B | $4.96B | $2.72B | $4.30B |
| EBITDA | $4.91B | $7.65B | $6.72B | $4.64B | $5.77B |
| EPS (basic) | 1.89 | 3.44 | 3.64 | 1.97 | 3.06 |
| EPS (diluted) | 1.89 | 3.42 | 3.62 | 1.96 | 3.04 |
| Dividends declared per share | 1.94 | 1.79 | 1.62 | 1.47 | — |
| Weighted avg. shares (diluted) | 1.30B | 1.35B | 1.37B | 1.39B | 1.41B |
| Balance sheet | |||||
| Cash & equivalents | $2.19B | $1.40B | $1.88B | $1.95B | $3.55B |
| Receivables | $3.90B | $3.87B | $3.63B | $3.09B | $2.34B |
| Inventory | $4.42B | $3.83B | $3.62B | $3.38B | $2.71B |
| Current assets | $12.95B | $13.24B | $11.70B | $10.09B | $10.34B |
| PP&E, net | $10.67B | $9.48B | $9.69B | $9.02B | $8.66B |
| Goodwill | $24.34B | $23.02B | $23.90B | $23.45B | $21.98B |
| Intangibles | $19.63B | $18.85B | $19.84B | $19.71B | $18.29B |
| Total assets | $71.49B | $68.50B | $71.39B | $71.16B | $67.09B |
| Current liabilities | $21.86B | $19.55B | $19.01B | $16.73B | $14.01B |
| Short-term debt | $2.69B | $71.00M | $420.00M | $2.30B | $216.00M |
| Long-term debt | $17.22B | $15.66B | $16.89B | $20.25B | $17.55B |
| Total debt | $19.91B | $15.73B | $17.31B | $22.55B | $17.77B |
| Total liabilities | $45.60B | $41.54B | $43.02B | $44.24B | $38.77B |
| Shareholders' equity | $25.84B | $26.93B | $28.33B | $26.88B | $28.27B |
| Net debt | $17.71B | $14.34B | $15.42B | $20.60B | $14.21B |
| Cash flow statement | |||||
| Operating cash flow | $4.51B | $4.91B | $4.71B | $3.91B | $4.14B |
| Capital expenditure | $1.28B | $1.39B | $1.11B | $906.00M | $965.00M |
| Free cash flow | $3.23B | $3.52B | $3.60B | $3.00B | $3.18B |
| Investing cash flow | -$1.20B | $526.00M | $2.81B | -$4.89B | -$26.00M |
| Financing cash flow | -$2.76B | -$5.78B | -$7.56B | -$456.00M | -$4.07B |
| Depreciation & amortization | $1.36B | $1.30B | $1.22B | $1.11B | $1.11B |
| Stock-based compensation | $114.00M | $147.00M | $146.00M | $120.00M | $121.00M |
| Dividends paid | $2.49B | $2.35B | $2.16B | $1.99B | $1.83B |
| Share buybacks | $2.38B | $2.33B | $1.55B | $2.02B | $2.11B |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.